Why Rocket Lab USA, Inc. (RKLB) Stock Rose 6.5% on Nov 10, 2026
as of Tuesday, 4:48 PM ET
The reason we found
Record revenue and backlog lift Rocket Lab shares
Rocket Lab reported record third-quarter revenue of $267.8 million, up 72.7% year over year, while its $3.6 billion backlog and stronger sales outlook support continued demand. Although the company posted a loss and Neutron timing remains important, investors appear focused on growth and upcoming operational milestones.
earnings and business updatehigh confidence
Sources 13
- Rocket Lab (RKLB) Stock Forecast & Analyst Price Targetsstockanalysis.com
- Rocket Lab Rebounds After Mixed Q3 Report, Analysts Say Neutron Timing Is Keyinvestors.com
- Space stocks Rocket Lab, AST SpaceMobile on the move following earnings, operational updatesfinance.yahoo.com
- Rocket Lab (RKLB) Stock Price & Overviewstockanalysis.com
- Rocket Lab Rebounds After Mixed Q3 Report, Analysts Say Neutron Timing Is Keyfinnhub.io
- Space stocks Rocket Lab, AST SpaceMobile on the move following earnings, operational updatesfinnhub.io
- Rocket Lab's Record Quarter Sends Shares into Orbitfinnhub.io
- Rocket Lab earnings: what to look for from RKLBfinnhub.io
- Rocket Lab (RKLB) Q3 2026 Earnings Call Transcriptfinnhub.io
- AST SpaceMobile Sinks 8% on Q3 Miss as BofA Slashes Target to $45 Over Rocket Riskfinnhub.io
- RKLB Stock Draws Wall Street’s Attention – Cantor Sees Attractive Entry Point Ahead Of These Two Key Eventsfinnhub.io
- Rocket Lab (RKLB) stock price forecast: Record $3.6 bn backlog and Q3 earnings reshape 2027 outlook - Beinsurenews.google.com
- Rocket Lab (NASDAQ:RKLB) reports bullish Q3 2026, guides for strong sales next quarterfinance.yahoo.com
Our call
Buy moredated Nov 11, 2026
Rocket Lab USA's sales grew 59% over the past year, and four more analysts rate it a buy than three months ago. We'd stop buying if Rocket Lab USA's next report shows sales growth below 30% or misses profit forecasts.
Other moves on Nov 10
- HIMS−16.5%Earnings miss and weaker outlook trigger Hims & Hers selloff
- LFVN−13.6%LifeVantage Stock Falls After Revenue Drops 22%
- QLYS−13.3%Qualys Falls Despite Earnings Beat on Tepid Revenue Outlook
- ACAD+10.7%Revenue Beat and Guidance Lift Acadia Shares
- ASTS−8.7%AST SpaceMobile slides after earnings miss and price-target cut
- BDSX−8.5%Analyst trims Biodesix target despite maintaining Buy rating